Literature DB >> 11852340

Assessment of ileoanal pouch inflammation by interleukin 1beta and interleukin 8 concentrations in the gut lumen.

N Evgenikos1, D C C Bartolo, D W Hamer-Hodges, S Ghosh.   

Abstract

PURPOSE: The cytokines interleukin 1beta and interleukin 8 have previously been shown to be present in mucosal biopsy specimens from inflamed ileoanal pouches. Our aim was to use the method of whole gut lavage fluid to measure cytokine concentrations and relate these to disease activity.
METHODS: Forty-two patients with ulcerative colitis were recruited (23 males). Their ages ranged from 20 to 73 years (median 39). A questionnaire was completed and whole gut lavage, pouchoscopy, and biopsy were performed.
RESULTS: Both interleukin 1beta and interleukin 8 were present in the whole gut lavage fluid of ileoanal pouches, with concentrations ranging from 4 to 143 pg/ml (median 6.3 pg/ml) for whole gut lavage fluid interleukin 1beta and from 18 to 1000 pg/ml (median 53.7 pg/ml) for whole gut lavage fluid interleukin 8. Whole gut lavage fluid interleukin 1beta and interleukin 8 were simultaneously detectable in 24 patients. These included the five patients with pouchitis, who had higher levels of interleukin 1beta (75 pg/ml vs. 8 pg/ml, P < 0.005) and interleukin 8 (668 pg/ml vs. 106 pg/ml, P < 0.005) compared with the rest of the patients with detectable cytokines (n = 19). The sensitivity of whole gut lavage fluid interleukin 8 (>200 pg/ml) in the diagnosis of pouchitis was 1, and the specificity was 0.86. There was a significant positive correlation of both whole gut lavage fluid interleukin 1beta and interleukin 8 with all the gut protein loss markers (immunoglobulin G, albumin, alpha1-antitrypsin).
CONCLUSION: Cytokine interleukin 1beta and interleukin 8 concentrations, along with other parameters of inflammation, are raised in pouchitis in the whole gut lavage. The results also suggest a spectrum of severity of "pouchitis," with clinical pouchitis fulfilling Moskowitz criteria at the severe end of the spectrum.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11852340     DOI: 10.1007/s10350-004-6156-6

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  9 in total

1.  Activation of signal transducer and activator of transcription-1 (STAT-1) and differential expression of interferon-gamma and anti-inflammatory proteins in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis.

Authors:  R F Leal; M L S Ayrizono; M Milanski; A Coope; J J Fagundes; L A Velloso; C S R Coy
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

2.  Increased cytokine transcripts in pouchitis reflect the degree of inflammation but not the underlying entity.

Authors:  C Schmidt; T Giese; B Ludwig; M Menges; M Schilling; S C Meuer; S Zeuzem; A Stallmach
Journal:  Int J Colorectal Dis       Date:  2005-08-23       Impact factor: 2.571

Review 3.  Pouchitis: insight into the pathogenesis and clinical aspects.

Authors:  Leandro Minatel Vidal de Negreiros; Lívia Bitencourt Pascoal; Lívia Moreira Genaro; Julian Furtado Silva; Bruno Lima Rodrigues; Michel Gardere Camargo; Carlos Augusto Real Martinez; Cláudio Saddy Rodrigues Coy; Maria de Lourdes Setsuko Ayrizono; João José Fagundes; Raquel Franco Leal
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

Review 4.  Rectal effluent as a research tool.

Authors:  Jana M Rocker; Jack A DiPalma; Lewis K Pannell
Journal:  Dig Dis Sci       Date:  2014-09-02       Impact factor: 3.199

5.  Differential expression of pro-inflammatory cytokines and a pro-apoptotic protein in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis.

Authors:  R F Leal; C S R Coy; M L S Ayrizono; J J Fagundes; M Milanski; M J Saad; L A Velloso; J R N Góes
Journal:  Tech Coloproctol       Date:  2008-05-30       Impact factor: 3.781

6.  Leukocytapheresis for the treatment of active pouchitis: a pilot study.

Authors:  Yasumi Araki; Keiichi Mitsuyama; Takaaki Nagae; Yuji Tou; Motonori Nakagawa; Yasue Iwatani; Masakazu Harada; Hiroyuki Ozasa; Michio Sata; Toshihiro Noake
Journal:  J Gastroenterol       Date:  2008-07-23       Impact factor: 7.527

Review 7.  Infliximab for the treatment of pouchitis.

Authors:  Maddalena Zippi; Claudio Cassieri; Eleonora Veronica Avallone; Roberta Pica
Journal:  World J Clin Cases       Date:  2013-09-16       Impact factor: 1.337

8.  Role of the SOS Response in the Generation of Antibiotic Resistance In Vivo.

Authors:  John K Crane; Cassandra L Alvarado; Mark D Sutton
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

9.  Effects of Jian Pi Qing Chang Hua Shi decoction on mucosal injuries in a 2,4,6-trinitrobenzene sulphonic acid-induced inflammatory bowel disease rat model.

Authors:  Huicun Zhang; Na Ta; Hong Shen; Hongbing Wang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.